Bloomberg Law
July 31, 2020, 3:37 PM

Quidel in Preliminary Pact With NIH on Virus Tests

Erin McClam
Erin McClam
Bloomberg News

Quidel says it has entered a preliminary letter contract with NIH to support expansion of manufacturing capacity for assays that test for SARS-CoV-2 Antigen.

  • Quidel and NIH endeavor to enter into a definitive agreement to support the initiative by mid-September
  • Company says NIH RADx-ATP investment would support upgrade and addition of manufacturing lines, expanding capacity for test cassettes from approximately 84 million cassettes per year to in excess of 220 million cassettes per year

To view the source of this information click here

To contact the reporter on this story:
Erin McClam in New York at

To contact the ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.